awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47561666-79EA6C8C-F5C4-4C20-8962-3240AE75AD87
Q47561666-79EA6C8C-F5C4-4C20-8962-3240AE75AD87
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47561666-79EA6C8C-F5C4-4C20-8962-3240AE75AD87
p53-reactive T cells are associated with clinical benefit in patients with platinum-resistant epithelial ovarian cancer after treatment with a p53 vaccine and gemcitabine chemotherapy.
P2860
Q47561666-79EA6C8C-F5C4-4C20-8962-3240AE75AD87
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47561666-79EA6C8C-F5C4-4C20-8962-3240AE75AD87
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
350d649034512fb808968476e4c784c357a45ba4
P2860
A phase 1/2 study combining gemcitabine, Pegintron and p53 SLP vaccine in patients with platinum-resistant ovarian cancer.